Telli T, Tuncel M, Karabulut E, Aksoy S, et al. Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with (177) Lu-PSMA-617. A single-center prospective observational study. Prostate 2023 Mar 15. doi: 10.1002/pros.24518.
PMID: 36919876